European Journal of Internal Medicine
Volume 20, Issue 3 , Pages 296-300 , May 2009

Implications of routinely measuring Ankle-Brachial Index (ABI) among patients attending at a Lipid Clinic

Received 19 June 2008 ,Revised 21 July 2008 ,Accepted 24 September 2008.

References 

  1. Beswick A, Brindle P. Risk scoring in the assessment of cardiovascular risk. Curr Opin Lipidol. 2006;17:375–386
  2. Law MR, Wald NJ, Morris JK. The performance of blood pressure and other cardiovascular risk factors as screening tests for ischemic heart disease and stroke. J Med Screen. 2004;11:3–7
  3. Jackson R, Lawes CM, Bennet DA Milne RJ, Rodgers A. Treatment with drugs to lower blood pressure and blood cholesterol based on an individual's absolute cardiovascular risk. Lancet. 2005;365:434–441
  4. Cobb FR, Kraus WE, Root M, Allen JD. Assessing risk for coronary heart disease: beyond Framingham. Am Heart J. 2003;146:572–580
  5. Wang TJ, Gona P, Larson MG, Tofler JH, Levy D, Newton-Cheh C, et al. Multiple biomarkers for the prediction of first major cardiovascular events and death. N Engl J Med. 2006;355:2631–2639
  6. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Eng J Med. 1999;340:14–22
  7. Lakoski SG, Greenland P, Wong ND, Schreiner PJ, Herrington DM, Kronmal RA, et al. Coronary artery calcium scores and risk for cardiovascular events in women classified as “low risk” based on Framingham risk score: the multi-ethnic study of atherosclerosis (MESA). Arch Intern Med. 2007;167:2437–2442
  8. Abbott RD, Ueshima H, Masaki KH, Willcox BJ, Rodriguez BL, Ikeda A, et al. Coronary artery calcification and total mortality in elderly men. J Am Geriatr Soc. 2007;55:1948–1954
  9. Creager MA. Medical management of peripheral arterial disease. Cardiol Rev. 2001;9:238–245
  10. Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CV, Creager MA, Halperin JL, et al. ACC/AHA guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the America Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines. J Am Coll Cardiol. 2006;47:1239–1312
  11. Heald CL, Fowkes FG, Murray JD, Price JF. Risk of mortality and cardiovascular disease associated to the ankle-brachial index: systematic review. Atherosclerosis. 2006;189:61–69
  12. Criqui MH, Langer RD, Fronek A, Feigelson HF, Klauber MR, Mc Cann TJ, et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med. 1992;326:381–386
  13. De Backer G, Ambrosioni E, Borch-Johnsen K, Brotons C, Cifkova R, Dallongeville J, et al. European Guidelines on cardiovascular disease prevention in clinical practice. Third joint task force of European and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and by invited experts). Eur J Cardiovasc Prev Rehab. 2003;10:S1–S10
  14. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults: executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486–2497
  15. Lee AJ, Price JF, Russell MJ, Smith FB, van Wijk MC, Fowkes FG. Improved prediction of fatal myocardial infarction using the ankle-brachial index in addition to conventional risk factors. The Edinburgh Artery Study. Circulation. 2004;110:3075–3080
  16. Golomb BA, Dang TT, Criqui MH. Peripheral arterial disease: morbidity and mortality implications. Circulation. 2006;114:688–699
  17. Belch JJ, Topol EJ, Agnelli G, Bertrand M, Califf RM, Clement DL, et al. Prevention of atherothrombotic disease network. Critical issues in peripheral arterial disease detection and management. A call to action. Arch Intern Med. 2003;163:884–892
  18. Simon A, Chironi G, Levenson J. Comparative performance of subclinical atherosclerosis tests in predicting coronary heart disease in asymptomatic individuals. Eur Heart J. 2007;28:2967–2971
  19. Bo M, Comba M, Canade A, Brescianini A, Corsinovi L, Astengo MA, et al. Clinical implications of white-coat effect among patients attending at a lipid clinic. Atherosclerosis 2007, Electronic publication ahead of print.
  20. World Health Organization . Physical status: the use and the interpretation of anthropometry. Geneva: World Health Organization; 1995;
  21. Bo M, Raspo S, Morra F, Isaia G, Cassader M, Fabris F, et al. Body fat and C-reactive protein levels in healthy non-obese men. Nutr Metab Cardiovasc Dis. 2004;14:66–72
  22. Greenland P, Abrams J, Aurigemma GP, Bond MG, Clark LT, Criqui RH, et al. Prevention Conference V: beyond secondary prevention: identifying the high-risk patient for primary prevention: noninvasive tests of atherosclerotic burden: Writing Group III. Circulation. 2000;101:E16–22
  23. Ankle Brachial Index Collaboration . Ankle brachial index combined with Framingham risk score to predict cardiovascular events and mortality. A meta-analysis. JAMA. 2008;300:197–208
  24. Ferrario M, Chiodini P, Chambless LE, Cesana C, Vannuzzo G, Panico S, et al. Prediction of coronary events in a low incidence population: assessing accuracy of the CUORE Cohort Study prediction equation. Int J Epidemiol. 2005;34:413–421
  25. Menotti A, Lanti M, Puddu PE. Comparison of the Framingham risk function-based coronary chart with risk function from an Italian population study. Eur Heart J. 2000;21:365–370
  26. Leng GC, Fowkes FGR, Lee AJ, Dunbar J, Housley E, Ruckley CV. Use of ankle brachial pressure index to predict cardiovascular events and death: a cohort study. BMJ. 1996;313:1440–1444
  27. 2007 Guidelines for the management of arterial hypertension . The task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2007;25:1105–1187
  28. Kullo IJ, Malik AR. Arterial ultrasonography and tonometry as adjuncts to cardiovascular risk stratification. J Am Coll Cardiol. 2007;49:1413–1426
  29. Meijer WT, Hoes AW, Rutgers D, Bots LM, Hofman A, Grobbee DE. Peripheral arterial disease in the elderly: the Rotterdam study. Arterioscler Thromb Vasc Biol. 1998;18:185–192
  30. Newman AB, Shemanski L, Manolio TA, Cushman M, Mittelmark M, Polak JF, et al. Ankle arm index as a predictor of cardiovascular disease and mortality in the Cardiovascular Health Study. Arterioscler Thromb Vasc Biol. 1999;19:538–545
  31. Ogren M, Hedblad B, Engstrom G, Janzon L. Prevalence and prognostic significance of asymptomatic peripheral arterial disease in 68-year old men with diabetes. Results from the population study “men born in 1914” from Malmo, Sweden. Eur J Vasc Endovasc Surg. 2005;29:182–189

PII: S0953-6205(08)00267-7

doi: 10.1016/j.ejim.2008.09.006

European Journal of Internal Medicine
Volume 20, Issue 3 , Pages 296-300 , May 2009

Article Tools